Benchling Raises $50M to Accelerate Life Science R&D Globally

Benchling is announcing a $50M Series D investment, led by Alkeon Capital with participation from new investors Spark Capital, Lux Capital, and ICONIQ Partners, as well as existing investors Thrive Capital, Menlo Ventures, and Benchmark. We are thrilled to have these long-term partners on our journey. 

The ongoing pandemic has put biotechnology under the global spotlight. As scientists race to develop treatments and vaccines for COVID-19 on an unprecedented timescale, we’re seeing how far life science has come.

[Read More]

Please to read the entire article.